Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × omipalisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Uveal Melanoma 1 Neurofibromatosis 1 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 382 Rituximab 330 Etoposide 190 Vincristine 176 Filgrastim 172 Doxorubicin 170 Prednisone 143 Radiotherapy 136 Cytarabine 133 fludarabine phosphate 121 Methotrexate 110 Melphalan 110 Peripheral Blood Stem Cell Transplantation 107 fludarabine 101 Busulfan 85 Dexamethasone 74 Carmustine 63 Granulocyte Colony-Stimulating Factor 60 Tacrolimus 59 Mycophenolic Acid 56 Gemcitabine 56 Whole-Body Irradiation 55 Bendamustine Hydrochloride 55 Antilymphocyte Serum 54 Lenalidomide 52 Cyclosporine 51 Ifosfamide 50 Bortezomib 49 Methylprednisolone 42 Leucovorin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00972686 2017-05-09

FTIH

GlaxoSmithKline

Phase 1 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡